Effect of levothyroxine replacement therapy on paraoxonase-1 and carotid intima-media thickness in subclinical hypothyroidism

Medical Science Monitor

Volumn 16, Issue 1, 2010, Pages

  Kebapcilar, Levent ^a   Comlekci, Abdurrahman ^a   Tuncel, Pinar ^a   Solak, Ahmet ^a   Secil, Mustafa ^a   Gencel, Omur ^a   Sahin, Mustafa ^b   Sari, Ismail ^a   Yeşil, Sena ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Carotid intima media thickness; Paraoxonase 1; Subclinical hypothyroidism

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVOTHYROXINE; LIOTHYRONINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE INCREASE; ENZYME ACTIVITY; EUTHYROIDISM; FEMALE; HUMAN; HYPOTHYROIDISM; LIPID BLOOD LEVEL; MALE; SUBSTITUTION THERAPY; THYROTROPIN BLOOD LEVEL;

ADULT; ARYLDIALKYLPHOSPHATASE; BLOOD CHEMICAL ANALYSIS; BODY MASS INDEX; BODY WEIGHTS AND MEASURES; C-REACTIVE PROTEIN; CAROTID ARTERIES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; STATISTICS, NONPARAMETRIC; THYROXINE; TUNICA INTIMA;

EID: 75149117268     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Danese MD, Ladenson PW, Meinert CL, Powe NR: Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab, 2000; 85: 2993-3001
2. Taddei S, Caraccio N, Virdis A et al: Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab, 2003; 88: 3731-37
3. Canturk Z, Cetinarslan B, Tarkun I et al: Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid, 2003; 13: 971-77
4. Frey B, Haupt R, Alms S et al: Increase in fragmented phosphatidylcholine in blood plasma by oxidative stress. J Lipid Res, 2000; 41: 1145-53
5. Mackness B, Durrington PN, Mackness MI: Human serum paraoxonase. Gen Pharmacol, 1998; 31: 329-36
6. Mackness B, Durrington P, McElduff P et al: Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation, 2003; 107: 2775-79
7. Azizi F, Raiszadeh F, Solati M et al: Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest, 2003; 26: 703-9
8. Baskol G, Atmaca H, Tanriverdi F et al: Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes, 2007; 115: 522-26
9. Milionis HJ, Tambaki AP, Kanioglou CN et al: Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect. Thyroid, 2005; 15: 455-60
10. Miller M, Zhan M, Havas S: High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med, 2005; 165: 2063-68
11. Cakal E, Turgut AT, Demirbas B et al: Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism. Exp Clin Endocrinol Diabetes, 2008 Sep 30 [Epub ahead of print]
12. Baldassarre D, Amato M, Bondioli A et al: Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke, 2000; 31: 2426-30
13. Monzani F, Caraccio N, Kozakowa M et al: Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab, 2004; 89: 2099-106
14. Bensen JT, Li R, Hutchinson RG et al: Family history of coronary heart disease and pre-clinical carotid artery atherosclerosis in African-Americans and whites: the ARIC study: Atherosclerosis Risk in Communities. Genet Epidemiol, 1999; 16: 165-78
15. Sidhu PS, Desai SR: A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery. Br J Radiol, 1997; 70: 85-89
16. Mackness MI, Harty D, Bhatnagar D et al: Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis, 1991; 86: 193-99
17. Becker C: Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev, 1985; 6: 432-40
18. Vanderpump MP, Tunbridge WM, French JM et al: The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid, 1996; 6: 155-60
19. Taddei S, Caraccio N, Virdis A et al: Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab, 2003; 88: 3731-37
20. Heiss G, Sharrett AR, Barnes R et al: Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol, 1991; 134: 250-56
21. Bots ML, Hoes AW, Koudstaal PJ et al: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation, 1997; 96: 1432-37
22. Bots ML, Hoes AW, Hofman A et al: Cross-sectionally assessed carotid intima-media thickness relates to long-term risk of stroke, coronary heart disease and death as estimated by available risk functions. J Intern Med, 1999; 245: 269-76
23. Watson AD, Berliner JA, Hama SY et al: Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biochemical activity of minimally oxidized low density lipoprotein. J Clin Invest, 1995; 96: 2882-91
24. Mackness MI, Mackness B, Durrington PN et al: Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol, 1996; 7: 69-76
25. Balcerzyk A, Zak I, Krauze J: Protective effect of R allele of PON1 gene on the coronary artery disease in the presence of specific genetic background. Dis Markers, 2008; 24: 81-88
26. Balcerzyk A, Zak I, Krauze J: Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease. Arch Med Res, 2007; 38: 545-50
27. Mackness B, Mackness MI, Arrol S et al: Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol, 1997; 122: 265-68
28. Tracy RP, Psaty BM, Macy E et al: Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol, 1997; 17: 2167-76
29. Kannel WB: High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am J Cardiol, 1983; 52: 9-12B
30. Castelli WP: Cardiovascular disease and multifactorial risk: challenge of the 1980s. Am Heart J, 1983; 106: 1191-200
31. Assmann G, Cullen P, Schulte H: The Münster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J, 1998; 19(Suppl.A): A2-11
32. Cremer P, Nagel D, Mann H et al: Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. Atherosclerosis, 1997; 129: 221-30
33. Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R et al: Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet, 2007; 370: 1829-39
34. Kannel WB, Vasan RS, Keyes MJ et al: Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort). Am J Cardiol, 2008; 101: 497-501
35. Blackburn R, Giral P, Bruckert E et al: Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol, 2001; 21: 1962-68
36. Kivimaki M, Lawlor DA, Juonala M et al: Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study. Arterioscler Thromb Vasc Biol, 2005; 25: 2197-202
37. Hee Choi S, Chang Kim H, Woo Ahn C et al: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Eur J Cardiovasc Prev Rehabil, 2005; 12: 548-54
38. Hashimoto H, Kitagawa K, Hougaku H et al: C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation, 2001; 104: 63-67
39. Xiang GD, He YS, Zhao LS et al: Impairment of endothelium-dependent arterial dilation in Hashimoto's thyroiditis patients with euthyroidism. Clin Endocrinol (Oxf), 2006; 64: 698-702
40. Hak AE, Pols HA, Visser TJ et al: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med, 2000; 132: 270-78
41. Adrees M, Gibney J, El-Saeity N, Boran G: Effects of 18 months of L-Thyroxine replacement in women with subclinical hypothyroidism. Clin Endocrinol (Oxf), 2008 Dec 15. [Epub ahead of print]
42. Peleg RK, Efrati S, Benbassat C et al: The effect of levothyroxine on arterial stiffness and lipid profile in patients with subclinical hypothyroidism. Thyroid, 2008; 18: 825-30